-
1
-
-
32944482013
-
Plant, synthetic, and endogenous cannabinoids in medicine
-
DI MARZO VD, PETROCELLIS LD: Plant, synthetic, and endogenous cannabinoids in medicine. Ann. Rev. Med. (2006) 57:553-574.
-
(2006)
Ann. Rev. Med.
, vol.57
, pp. 553-574
-
-
Di Marzo, V.D.1
Petrocellis, L.D.2
-
3
-
-
0025325535
-
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
-
MATSUDA LA, LOLAIT SJ, BROWNSTEIN MJ, YOUNG AC, BONNER TI: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (1990) 346(6284):561-564.
-
(1990)
Nature
, vol.346
, Issue.6284
, pp. 561-564
-
-
Matsuda, L.A.1
Lolait, S.J.2
Brownstein, M.J.3
Young, A.C.4
Bonner, T.I.5
-
4
-
-
33646571242
-
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain
-
CRISTINO L, DE PETROCELLIS L, PRYCE G, BAKER D, GUGLIELMOTTI V, DI MARZO V: Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience (2006) 139(4):1405-1415.
-
(2006)
Neuroscience
, vol.139
, Issue.4
, pp. 1405-1415
-
-
Cristino, L.1
De Petrocellis, L.2
Pryce, G.3
Baker, D.4
Guglielmotti, V.5
Di Marzo, V.6
-
5
-
-
0027515373
-
Molecular characterization of a peripheral receptor for cannabinoids
-
MUNRO S, THOMAS KL, ABU-SHAAR M: Molecular characterization of a peripheral receptor for cannabinoids. Nature (1993) 365:61-65.
-
(1993)
Nature
, vol.365
, pp. 61-65
-
-
Munro, S.1
Thomas, K.L.2
Abu-Shaar, M.3
-
6
-
-
32844465920
-
2 receptors: Immunohistochemical localization in rat brain
-
2 receptors: immunohistochemical localization in rat brain. Brain Res. (2006) 1071(1):10-23.
-
(2006)
Brain Res.
, vol.1071
, Issue.1
, pp. 10-23
-
-
Gong, J.P.1
Onaivi, E.S.2
Ishiguro, H.3
-
7
-
-
33645106816
-
2 receptor-mediated antihyperalgesia: Possible direct involvement of neural mechanisms
-
2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur. J. Neurosci. (2006) 23(6):1530-1538.
-
(2006)
Eur. J. Neurosci.
, vol.23
, Issue.6
, pp. 1530-1538
-
-
Beltramo, M.1
Bernardini, N.2
Bertorelli, R.3
-
8
-
-
30344476972
-
In silico parent searching reveals a new cannabinoid receptor
-
BAKER D, PRYCE G, DAVIES WL, HILEY CR: In silico parent searching reveals a new cannabinoid receptor. Trends Pharmacol. Sci. (2006) 27(1):1-4.
-
(2006)
Trends Pharmacol. Sci.
, vol.27
, Issue.1
, pp. 1-4
-
-
Baker, D.1
Pryce, G.2
Davies, W.L.3
Hiley, C.R.4
-
9
-
-
33646814424
-
Cannabinoid receptors and endocannabinoids: Evidence for new players
-
MACKIE K, STELLA N: Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J. (2006) 8:E298-E306.
-
(2006)
AAPS J.
, vol.8
-
-
Mackie, K.1
Stella, N.2
-
10
-
-
0346350327
-
The cannabinoid system and immune modulation
-
KLEIN TW, NEWTON C, LARSEN K et al.: The cannabinoid system and immune modulation. J. Leukoc. Biol. (2003) 74:486-496.
-
(2003)
J. Leukoc. Biol.
, vol.74
, pp. 486-496
-
-
Klein, T.W.1
Newton, C.2
Larsen, K.3
-
11
-
-
0034685707
-
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor
-
BUCKLEY NE, MCCOY KL, MEZEY E et al.: Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol. (2000) 396:141-149.
-
(2000)
Eur. J. Pharmacol.
, vol.396
, pp. 141-149
-
-
Buckley, N.E.1
McCoy, K.L.2
Mezey, E.3
-
12
-
-
22044449933
-
2 receptor negatively regulates IL-12p40 production in murine macrophages: Role of IL-10 and ERK1/2 kinase signaling
-
2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling. Br. J. Pharmacol. (2005) 145(4):441-448.
-
(2005)
Br. J. Pharmacol.
, vol.145
, Issue.4
, pp. 441-448
-
-
Correa, F.1
Mestre, L.2
Docagne, F.3
Guaza, C.4
-
13
-
-
0037255987
-
Pharmacokinetics and pharmacodynamics of cannabinoids
-
GROTENHERMEN F: Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. (2003) 42:327-360.
-
(2003)
Clin. Pharmacokinet.
, vol.42
, pp. 327-360
-
-
Grotenhermen, F.1
-
15
-
-
33745280979
-
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator activated receptor{gamma} independently of cannabinoid receptors 1 and 2
-
(Epub ahead of print)
-
ROCKWELL CE, SNIDER NT, THOMPSON JT, VANDEN HEUVEL JP, KAMINSKI NE: Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator activated receptor{gamma} independently of cannabinoid receptors 1 and 2. Mol. Pharmacol. (2006) (Epub ahead of print).
-
(2006)
Mol. Pharmacol.
-
-
Rockwell, C.E.1
Snider, N.T.2
Thompson, J.T.3
Vanden Heuvel, J.P.4
Kaminski, N.E.5
-
16
-
-
27744460312
-
The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner
-
CURRAN NM, GRIFFIN BD, O'TOOLE D, BRADY KJ, FITZGERALD SN, MOYNAGH PN: The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner. J. Biol. Chem. (2005) 280(43):35797-35806.
-
(2005)
J. Biol. Chem.
, vol.280
, Issue.43
, pp. 35797-35806
-
-
Curran, N.M.1
Griffin, B.D.2
O'Toole, D.3
Brady, K.J.4
Fitzgerald, S.N.5
Moynagh, P.N.6
-
17
-
-
0033614984
-
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
-
ZYGMUNT PM, PETERSSON J, ANDERSSON DA et al.: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (1999) 400(6743):452-457.
-
(1999)
Nature
, vol.400
, Issue.6743
, pp. 452-457
-
-
Zygmunt, P.M.1
Petersson, J.2
Andersson, D.A.3
-
18
-
-
0037216692
-
Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes
-
SOUTHALL MD, LI T, GHARIBOVA LS, PEI Y, NICOL GD, TRAVERS JB: Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J. Pharmacol. Exp. Ther. (2003) 304(1):217-222.
-
(2003)
J. Pharmacol. Exp. Ther.
, vol.304
, Issue.1
, pp. 217-222
-
-
Southall, M.D.1
Li, T.2
Gharibova, L.S.3
Pei, Y.4
Nicol, G.D.5
Travers, J.B.6
-
19
-
-
28844445067
-
Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems
-
ZHANG N, OPPENHEIM JJ: Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems. J. Leukoc. Biol. (2005) 78(6):1210-1214.
-
(2005)
J. Leukoc. Biol.
, vol.78
, Issue.6
, pp. 1210-1214
-
-
Zhang, N.1
Oppenheim, J.J.2
-
20
-
-
0033856751
-
Ajulemic acid (CT3): A potent analog of the acid metabolites of THC
-
BURSTEIN SH: Ajulemic acid (CT3): a potent analog of the acid metabolites of THC. Curr. Pharm. Des. (2000) 6(13):1339-1345.
-
(2000)
Curr. Pharm. Des.
, vol.6
, Issue.13
, pp. 1339-1345
-
-
Burstein, S.H.1
-
21
-
-
27644448758
-
Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials
-
BURSTEIN S: Ajulemic acid (IP-751): synthesis, proof of principle, toxicity studies, and clinical trials. AAPS J. (2005) 7(1):E143-E148.
-
(2005)
AAPS J.
, vol.7
, Issue.1
-
-
Burstein, S.1
-
22
-
-
23044475561
-
PPAR-gamma: A nuclear receptor with affinity for cannabinoids
-
BURSTEIN S: PPAR-gamma: a nuclear receptor with affinity for cannabinoids. Life Sci. (2005) 77(14):1674-1684.
-
(2005)
Life Sci.
, vol.77
, Issue.14
, pp. 1674-1684
-
-
Burstein, S.1
-
23
-
-
0141593561
-
Analgesic effecc of the synthetic cannabinoid CT-3 on chronic neuropathic pain: A randomized controlled trial
-
KARST M, SALIM K, BURSTEIN S, CONRAD I, HOY L, SCHNEIDER U: Analgesic effecc of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA (2003) 290(13):1757-1762.
-
(2003)
JAMA
, vol.290
, Issue.13
, pp. 1757-1762
-
-
Karst, M.1
Salim, K.2
Burstein, S.3
Conrad, I.4
Hoy, L.5
Schneider, U.6
-
24
-
-
0141677644
-
Short-term effects of cannabinoids in patients with HIV-1 infection: A randomized, placebo-controlled clinical trial
-
ABRAMS DI, HILTON JF, LEISER RJ et al.: Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann. Intern. Med. (2003) 139(4):258-66.
-
(2003)
Ann. Intern. Med.
, vol.139
, Issue.4
, pp. 258-266
-
-
Abrams, D.I.1
Hilton, J.F.2
Leiser, R.J.3
-
25
-
-
20444487825
-
Cannabinoid influence on cytokine profile in multiple sclerosis
-
KATONA S, KAMINSKI E, SANDERS H, ZAJICEK J: Cannabinoid influence on cytokine profile in multiple sclerosis. Clin. Exp. Immunol. (2005) 140(3):580-585.
-
(2005)
Clin. Exp. Immunol.
, vol.140
, Issue.3
, pp. 580-585
-
-
Katona, S.1
Kaminski, E.2
Sanders, H.3
Zajicek, J.4
-
26
-
-
0242654882
-
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial
-
ZAJICEK J, FOX P, SANDERS H et al.: Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet (2003) 362(9395):1517-1526.
-
(2003)
Lancet
, vol.362
, Issue.9395
, pp. 1517-1526
-
-
Zajicek, J.1
Fox, P.2
Sanders, H.3
-
27
-
-
0038449770
-
-
NO AUTHORS LISTED: (58th edn), Thomson Healthcare, Montvale, New Jersey, USA
-
NO AUTHORS LISTED: Physicians Desk Reference (58th edn), Thomson Healthcare, Montvale, New Jersey, USA (2004):3241-3243
-
(2004)
Physicians Desk Reference
, pp. 3241-3243
-
-
-
28
-
-
33749242498
-
The development of Sativex® - A natural cannabis-based medicine
-
In: Mechoulam R (Ed.), Birkhauser Verlag, Basel, Boston, Berlin
-
GUY GW, STOUT CG: The development of Sativex® - a natural cannabis-based medicine. In: Cannabinoids as Therapeutics. Milestones in Drug Therapy. Mechoulam R (Ed.), Birkhauser Verlag, Basel, Boston, Berlin (2005):231-260.
-
(2005)
Cannabinoids As Therapeutics. Milestones in Drug Therapy
, pp. 231-260
-
-
Guy, G.W.1
Stout, C.G.2
-
29
-
-
2942585608
-
Chemokine blockade: A new era in the treatment of rheumatoid arthritis?
-
HARINGMAN JJ, TAK PP: Chemokine blockade: a new era in the treatment of rheumatoid arthritis? Arthritis Res. Ther. (2004) 6:93-97.
-
(2004)
Arthritis Res. Ther.
, vol.6
, pp. 93-97
-
-
Haringman, J.J.1
Tak, P.P.2
-
33
-
-
0037089221
-
Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol
-
JORDA MA, VERBAKEL SE, VALK PJ et al.: Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood (2002) 99:2786-2793.
-
(2002)
Blood
, vol.99
, pp. 2786-2793
-
-
Jorda, M.A.1
Verbakel, S.E.2
Valk, P.J.3
-
35
-
-
7644244850
-
2-Arachidonoylglycerol, an endogenoet al.: Us cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils
-
OKA S, IKEDA S, KISHIMOTO S et al.: 2-Arachidonoylglycerol, an endogenoet al.: us cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. J. Leukoc. Biol. (2004) 76(5):1002-1009.
-
(2004)
J. Leukoc. Biol.
, vol.76
, Issue.5
, pp. 1002-1009
-
-
Oka, S.1
Ikeda, S.2
Kishimoto, S.3
-
38
-
-
10044257545
-
The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein
-
MAESTRONI GJM: The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. FASEB J. (2004) 18(15):1914-1916.
-
(2004)
FASEB J.
, vol.18
, Issue.15
, pp. 1914-1916
-
-
Maestroni, G.J.M.1
-
39
-
-
25444464434
-
Involvement of cannabinoid CB(2) recepcor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice
-
UEDA Y, MIYAGAWA N, MATSUI T, KAYA T, IWAMURA H: Involvement of cannabinoid CB(2) recepcor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur. J. Pharmacol. (2005) 520(1-3):164-171.
-
(2005)
Eur. J. Pharmacol.
, vol.520
, Issue.1-3
, pp. 164-171
-
-
Ueda, Y.1
Miyagawa, N.2
Matsui, T.3
Kaya, T.4
Iwamura, H.5
-
40
-
-
12444290061
-
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells
-
GOKOH M, KISHIMOTO S, OKA S et al.: 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells. Biochem. J. (2005) 386:583-589.
-
(2005)
Biochem. J.
, vol.386
, pp. 583-589
-
-
Gokoh, M.1
Kishimoto, S.2
Oka, S.3
-
41
-
-
33744948790
-
Effects of peripheral cannabionoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils
-
KURIHARA R, TOHYAMA Y, MATSUSAKA S et al.: Effects of peripheral cannabionoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils. J. Biol. Chem. (2006) 281:12908-12918.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 12908-12918
-
-
Kurihara, R.1
Tohyama, Y.2
Matsusaka, S.3
-
42
-
-
0033525711
-
Chemoattracrant receptor cross-desensitization
-
ALI H, RICHARDSON RM, HARIBABU B, SNYDERMAN R: Chemoattracrant receptor cross-desensitization. J. Biol. Chem. (1999) 274(10):6027-6030.
-
(1999)
J. Biol. Chem.
, vol.274
, Issue.10
, pp. 6027-6030
-
-
Ali, H.1
Richardson, R.M.2
Haribabu, B.3
Snyderman, R.4
-
43
-
-
33745627474
-
Adenosine A2a receptors induce heterologous desensitization of chemokine receptors
-
ZHANG N, YANG D, DONG H et al.: Adenosine A2a receptors induce heterologous desensitization of chemokine receptors. Blood (2006) 108(1):38-44.
-
(2006)
Blood
, vol.108
, Issue.1
, pp. 38-44
-
-
Zhang, N.1
Yang, D.2
Dong, H.3
-
44
-
-
20444484518
-
The target discovery process
-
EGNER U, KRATZSCHMAR J, KREFT B, POHLENZ HD, SCHNEIDER M: The target discovery process. Chembiochem. (2005) 6(3):468-479.
-
(2005)
Chembiochem.
, vol.6
, Issue.3
, pp. 468-479
-
-
Egner, U.1
Kratzschmar, J.2
Kreft, B.3
Pohlenz, H.D.4
Schneider, M.5
-
45
-
-
0041382826
-
Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10
-
FINE JS, ROJAS-TRIANA A, JACKSON JV et al.: Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10. Inflammation (2003) 27(4):161-174.
-
(2003)
Inflammation
, vol.27
, Issue.4
, pp. 161-174
-
-
Fine, J.S.1
Rojas-Triana, A.2
Jackson, J.V.3
-
46
-
-
0034594905
-
Cannabinoids control spasticity and tremor in a multiple sclerosis model
-
BAKER D, PRYCE G, CROXFORD JL et al.: Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature (2000) 404(6773):84-87.
-
(2000)
Nature
, vol.404
, Issue.6773
, pp. 84-87
-
-
Baker, D.1
Pryce, G.2
Croxford, J.L.3
-
49
-
-
16544377251
-
Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model
-
NI X, GELLER EB, EPPIHIMER MJ, EISENSTEIN TK, ADLER MW, TUMA RF: Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/ endothelial interactions in an experimental autoimmune encephalomyelitis model. Mult. Scler. (2004) 10:158-164.
-
(2004)
Mult. Scler.
, vol.10
, pp. 158-164
-
-
Ni, X.1
Geller, E.B.2
Eppihimer, M.J.3
Eisenstein, T.K.4
Adler, M.W.5
Tuma, R.F.6
-
51
-
-
33646596336
-
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
-
WITTING A, CHEN L, CUDABACK E et al.: Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc. Natl. Acad. Sci. USA (2006) 103(16):6362-6367.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, Issue.16
, pp. 6362-6367
-
-
Witting, A.1
Chen, L.2
Cudaback, E.3
-
52
-
-
0036260089
-
Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis
-
BRUNDULA V, REWCASTLE N, METZ LM, BERNARD C, YONG V: Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain (2002) 125(Pt 6):1297-308.
-
(2002)
Brain
, vol.125
, Issue.PART 6
, pp. 1297-1308
-
-
Brundula, V.1
Rewcastle, N.2
Metz, L.M.3
Bernard, C.4
Yong, V.5
-
53
-
-
0034727066
-
Multiple sclerosis
-
NOSEWORTHY J, LUCCHINETTI C, RODRIGUEZ M, WEINSHENKER B: Multiple sclerosis. N. Engl. J. Med. (2000) 343(13):938-952.
-
(2000)
N. Engl. J. Med.
, vol.343
, Issue.13
, pp. 938-952
-
-
Noseworthy, J.1
Lucchinetti, C.2
Rodriguez, M.3
Weinshenker, B.4
-
54
-
-
0031732074
-
The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients
-
WOLFE F, HAWLEY DJ: The longterm outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J. Rheumatol. (1998) 25:2108-2117.
-
(1998)
J. Rheumatol.
, vol.25
, pp. 2108-2117
-
-
Wolfe, F.1
Hawley, D.J.2
-
55
-
-
0347236888
-
Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission
-
MOLENAAR ET, VOSKUYL AE, DINANT HJ, BEZEMER PD, BOERS M, DIJKMANS BA: Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. (2004) 50:36-42.
-
(2004)
Arthritis Rheum.
, vol.50
, pp. 36-42
-
-
Molenaar, E.T.1
Voskuyl, A.E.2
Dinant, H.J.3
Bezemer, P.D.4
Boers, M.5
Dijkmans, B.A.6
-
57
-
-
27944510259
-
Cannabinoid receptor type 2 gene is associated with human osteoporosis
-
KARSAK M, COHEN-SOLAL M, FREUDENBERG J et al.: Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum. Mol. Genet. (2005) 14:3389-3396.
-
(2005)
Hum. Mol. Genet.
, vol.14
, pp. 3389-3396
-
-
Karsak, M.1
Cohen-Solal, M.2
Freudenberg, J.3
-
58
-
-
24344509882
-
Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies
-
SHANKAR BB, LAVEY BJ, ZHOU G et al.: Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies. Bioorg. Med. Chem. Lett. (2005) 15(20):4417-4420.
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, Issue.20
, pp. 4417-4420
-
-
Shankar, B.B.1
Lavey, B.J.2
Zhou, G.3
-
59
-
-
22544439953
-
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
-
IDRIS, AI, VAN'T HOF, RJ, GREIG, IR et al.: Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat. Med. (2005) 11:774-779.
-
(2005)
Nat. Med.
, vol.11
, pp. 774-779
-
-
Idris, A.I.1
Van't Hof, R.J.2
Greig, I.R.3
-
60
-
-
0038521050
-
Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation
-
NACKLEY AG, MAKRIYANNIS A, HOHMANN AG: Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience (2003) 119(3):747-757.
-
(2003)
Neuroscience
, vol.119
, Issue.3
, pp. 747-757
-
-
Nackley, A.G.1
Makriyannis, A.2
Hohmann, A.G.3
-
62
-
-
28544440521
-
2 receptor agonist activity in the hindpaw incision model of postoperative pain
-
2 receptor agonist activity in the hindpaw incision model of postoperative pain. Eur. J. Pharmacol. (2005) 527(1-3):172-174.
-
(2005)
Eur. J. Pharmacol.
, vol.527
, Issue.1-3
, pp. 172-174
-
-
Labuda, C.J.1
Koblish, M.2
Little, P.J.3
-
63
-
-
0033035659
-
SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist
-
PORTIER M, RINALDI-CARMONA M, PECCEU F et al.: SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J. Pharmacol. Exp. Ther. (1999) 288(2):582-589.
-
(1999)
J. Pharmacol. Exp. Ther.
, vol.288
, Issue.2
, pp. 582-589
-
-
Portier, M.1
Rinaldi-Carmona, M.2
Pecceu, F.3
-
64
-
-
0033575258
-
2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses
-
2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses. J. Biol. Chem. (1999) 274(29):20397-20405.
-
(1999)
J. Biol. Chem.
, vol.274
, Issue.29
, pp. 20397-20405
-
-
Bouaboula, M.1
Dussossoy, D.2
Casellas, P.3
-
65
-
-
12744258068
-
Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage
-
MBVUNDULA EC, BUNNING RA, RAINSFORD KD: Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage. Biochem. Pharmacol. (2005) 69(4):635-640.
-
(2005)
Biochem. Pharmacol.
, vol.69
, Issue.4
, pp. 635-640
-
-
Mbvundula, E.C.1
Bunning, R.A.2
Rainsford, K.D.3
-
69
-
-
0141649387
-
Bradykinin antagonists as anti-cancer agents
-
STEWART JM: Bradykinin antagonists as anti-cancer agents. Curr. Pharm. Des. (2003) 9(25):2036-2042.
-
(2003)
Curr. Pharm. Des.
, vol.9
, Issue.25
, pp. 2036-2042
-
-
Stewart, J.M.1
-
70
-
-
18144422077
-
Theoxyrocin receptor antagonist arosiban inhibits cell growth via a 'biased agonist' mechanism
-
REVERSI A, RIMOLDI V, MARROCCO T et al.: Theoxyrocin receptor antagonist arosiban inhibits cell growth via a 'biased agonist' mechanism. J. Biol. Chem. (2005) 280(16):16311-16318.
-
(2005)
J. Biol. Chem.
, vol.280
, Issue.16
, pp. 16311-16318
-
-
Reversi, A.1
Rimoldi, V.2
Marrocco, T.3
-
71
-
-
20244366860
-
Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice
-
REICH EP, CUI L, YANG L et al.: Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice. Eur. J. Immunol. (2005) 35(4):1027-1036.
-
(2005)
Eur. J. Immunol.
, vol.35
, Issue.4
, pp. 1027-1036
-
-
Reich, E.P.1
Cui, L.2
Yang, L.3
|